J Clin Neurol.  2020 Oct;16(4):633-645. 10.3988/jcn.2020.16.4.633.

Validation Study of the Official Korean Version of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale

Affiliations
  • 1Department of Neurology, Inje University, Haeundae Paik Hospital, Busan, Korea
  • 2Department of Neurology, Korea University Guro Hosipital, Korea University College of Medicine, Seoul, Korea
  • 3Department of Neurology, Soonchunhyang University Seoul Hospital, Soonchunhyang University School of Medicine, Seoul, Korea
  • 4Department of Neurology, Inje University Busan Paik Hospital, Busan, Korea
  • 5Department of Neurology, Inje University Busan Paik Hospital, Busan, Korea
  • 6Department of Neurology, Inje University Busan Paik Hospital, Busan, Korea
  • 7Department of Neurology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
  • 8Department of Neurology, Inje University Sanggye Paik Hospital, Seoul, Korea
  • 9Department of Neurology, Inje University Sanggye Paik Hospital, Seoul, Korea
  • 10Department of Neurology, Seoul Medical Center, Seoul, Korea
  • 11Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea
  • 12Department of Neurology, Samsung Medical center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 13Department of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, College of Medicine, Seoul National University, Seoul, Korea
  • 14Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
  • 15Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
  • 16Department of Neurology, University of Ulsan College of Medicine, Asan Medical center, Seoul, Korea
  • 17Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea
  • 18Department of Neurology, College of Medicine, Yeungnam University, Daegu, Korea
  • 19Department of Neurology, CHA University Bundang Medical Center, CHA University, Seongnam, Korea
  • 20Department of Neurology, Hanyang University College of Medicine, Seoul, Korea

Abstract

Background
and Purpose: The Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) is widely used for estimating the symptoms of Parkinson’s disease. Translation and validation of the MDS-UPDRS is necessary for non-English speaking countries and regions. The aim of this study was to validate the Korean version of the MDS-UPDRS.
Methods
Altogether, 362 patients in 19 centers were recruited for this study. We translated the MDS-UPDRS to Korean using the translation-back translation method and cognitive pretesting. We performed both confirmatory and exploratory factor analyses to validate the scale. We calculated the comparative fit index (CFI) for confirmatory factor analysis, and used unweighted least squares for exploratory factor analysis.
Results
The CFI was higher than 0.90 for all parts of the scale. Exploratory factor analysis also showed that the Korean MDS-UPDRS has the same number of factors in each part as the English version.
Conclusions
The Korean MDS-UPDRS has the same overall structure as the English MDSUPDRS. Our translated scale can be designated as the official Korean MDS-UPDRS.

Keyword

Parkinson’s diease; Movement Disorder Society Sponsored Revision of the Unified Parkinson’s Disease Rating Scale; validation; rating scale
Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error